DJIA 18,232.02 0.00 0.00%
NASDAQ 5,089.36 0.00 0.00%
S&P 500 2,126.06 0.00 0.00%
market minute promo

GlaxoSmithKline (NYSE: GSK)



company name or ticker
Company Photos
(Click to zoom)

Sector Leaders See 5.9% Advantage For 5 Highest-Yield, Lowest-Priced May Dividend Dogs

Analyst Says GlaxoSmithKline Acquisition Will Benefit Pfizer

9 International Dividend Dogs With Upside Potential

Buy-Rated Dividend Stocks: Top 3 Companies: DFT, GSK, ORI

Endo International Acquires Par Pharmaceuticals For $8 Billion

Following Hepatitis C, This Could Be the Next Disease Researchers Cure

With an effective cure for hepatitis C now in place after decades of research, we asked three of our top healthcare analysts which disease they believed researchers may cross off the list next. Here's what they had to say.

Illustrating Johnson & Johnson's Fair Value

Could an HIV/AIDS Vaccine Be a Reality By the End of the Decade?

New research at one California university leads to the hope of a possible effective HIV cure.

Oppenheimer: Buy Five Prime Therapeutics, It's Worth $45/Share

Why Agenus Can Continue To Rise After Doubling

See More Articles...